We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFAC.WS
326
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$20.9K ﹤0.01%
330,287
-100
-0% -$8
CCJ icon
327
PUT
Cameco
CCJ
$42.8B
$20.8K ﹤0.01%
+65,000
New +$1.53M
ONMDW icon
328
OneMedNet Corp Warrant
ONMDW
$1.05M
$20.4K ﹤0.01%
589,362
-29,465
-5% -$1.58K
RNERW
329
DELISTED
Mount Rainier Acquisition Corp. Warrant
RNERW
$20.3K ﹤0.01%
112,897
-34,803
-24% -$4.38K
DAVE icon
330
Dave Inc
DAVE
$3.91B
$20.3K ﹤0.01%
2,188
-937
-30% -$10K
SHUAW
331
DELISTED
SHUAA Partners Acquisition Corp I Warrant
SHUAW
$20K ﹤0.01%
221,640
-36,700
-14% -$2.31K
CCJ icon
332
CALL
Cameco
CCJ
$42.8B
$19.9K ﹤0.01%
+160,000
New +$3.76M
GRMLW
333
Greenland Mines Ltd Warrant
GRMLW
$18.9K ﹤0.01%
403,000
-348,089
-46% -$12.5K
ASCAR
334
DELISTED
A SPAC I Acquisition Corp. Right
ASCAR
$18.9K ﹤0.01%
221,998
-72,700
-25% -$5.86K
MBI icon
335
CALL
MBIA
MBI
$258M
$18.5K ﹤0.01%
+15,400
New +$176K
ENVX icon
336
CALL
Enovix
ENVX
$1.02B
$18.4K ﹤0.01%
+34,743
New +$427K
IFIN.WS
337
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
$18.2K ﹤0.01%
227,295
-37,100
-14% -$3.42K
AMC icon
338
CALL
AMC Entertainment Holdings
AMC
$2.18B
$17.9K ﹤0.01%
+5,190
New +$327K
PRPC.WS
339
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$17.8K ﹤0.01%
352,930
+31,587
+10% +$3.23K
BIOSW
340
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$17.8K ﹤0.01%
177,845
+27,895
+19% +$1.43K
CONXW
341
DELISTED
CONX Corp. Warrant
CONXW
$17.6K ﹤0.01%
117,205
+77,205
+193% +$12.7K
WINVW
342
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$17.5K ﹤0.01%
1,026,142
+2,100
+0.2% +$72
UPST icon
343
CALL
Upstart Holdings
UPST
$2.85B
$17.2K ﹤0.01%
+15,000
New +$290K
HIPO.WS
344
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$16.7K ﹤0.01%
520,703
+151,554
+41% +$6.77K
LCID icon
345
Lucid Motors
LCID
$2.61B
$16.4K ﹤0.01%
+240
New +$26.4K
APLS
346
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$16.4K ﹤0.01%
+5,700
New +$302K
ACAHW
347
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
$16.3K ﹤0.01%
325,739
+102,640
+46% +$5.24K
BZFD icon
348
BuzzFeed
BZFD
$92.5M
$16.2K ﹤0.01%
5,876
-67,360
-92% -$388K
NHICW
349
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$16.2K ﹤0.01%
89,800
-1,805
-2% -$124
VLATW
350
DELISTED
Valor Latitude Acquisition Corp. Warrant
VLATW
$15.8K ﹤0.01%
+528,335
New +$38K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.